Flow Cytometry Products and Services - Global Strategic Business Report: Capitalize on $1.7B Growth to $6.4B by 2030 as Thermo Fisher, Becton Dickinson, Beckman Coulter and Bio-Rad Battle for Share
The issuer is solely responsible for the content of this announcement.